$1.5MPre-Seed, 31 March 2026
Pre-seed to advance its next-generation lymphedema treatment
- Amount
- $1.5M
- Stage
- Pre-Seed
- Announced
- 31 March 2026
- Use of funds
- Pre-seed to advance its next-generation lymphedema treatment
- Checked
- Announced by the company
- Source
- Sub-Q Bionics closes $1.5M pre-seed pulse2.com